About
Overview
Leadership team
Board of directors
Partners
Contact
Approach
Overview
Scientific publications & presentations
Pipeline
Overview
TERN-701 (CML)
Metabolic Programs
Patients
Our commitment
Clinical trials
Resources
Expanded access
Investors
Overview
Press releases
Events and presentations
Stock information
SEC filings
Corporate governance
Email alerts
Careers
Culture
Values
Benefits
Open positions
About
Overview
Leadership team
Board of directors
Partners
Contact
Approach
Overview
Scientific publications & presentations
Pipeline
Overview
TERN-701 (CML)
Metabolic Programs
Patients
Our commitment
Clinical trials
Resources
Expanded access
Investors
Overview
Press releases
Events and presentations
Stock information
SEC filings
Corporate governance
Email alerts
Careers
Culture
Values
Benefits
Open positions
Facebook
Instagram
Twitter
LinkedIn
Initial Interim Results from Phase 1 CARDINAL Trial of TERN-701 for CML
12.3.24 AT 12:00 am EDT
Event Schedule
Register Now
Location Information
Contact Information
Additional Information
Tags
Share with friends